Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.
Zist Daru, ZIFERON
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls.
MS Research Roundup: May 16, 2014
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Episode 42 with Dr. Lawrence Steinman on amyloid in experimental autoimmune encephalomyelitis
EMD Serono Joins ACP to Launch OPT-UP Study
Viral triggers of multiple sclerosis.
FP187 – Oral Immunomodulatory Dimethyl Fumarate (DMF)
The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.
Mycophenolate mofetil for relapsing-remitting multiple sclerosis.
The pathology of acute disseminated encephalomyelitis produced experimentally in the rhesus monkey and its resemblance to human demyelinating disease.
Episode 49 with Dr. Hugh Rosen on sphingosine 1-phosphate receptor modulators
Seeing illness in art and medicine: a patient and printmaker collaboration.
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.
MS Research Roundup: July 18, 2014
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.
Mycophenolate mofetil therapy in the management of inflammatory bowel disease - A retrospective case series and review.
[Recommendations for a brief international cognitive assessment for multiple sclerosis].
National MS Society: Postdoctoral Fellowships
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study.
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis
Episode 37 with Dr. Jeanne Loring on human pluripotent stem cells in a mouse model of MS
Pages
« first
‹ previous
…
46
47
48
49
50
51
52
53
54
…
next ›
last »